Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Lancet Rheumatology 5, e508e522
Hospital credentialing requirements vary by institution
The most important advantage of the proposed hypothesis is not only the achievement of the therapeutic goal in managing GD but also the practically complete absence of side effects from the drugs used, which is very significant
The antibodies used for the immunoblot assays were: GCLC (Santa Cruz Biotech, #sc-390811), NQO1 (Sigma Prestige Antibodies, HPA007308), ACTIN (Sigma, A1978), NRF2 (Cell Signaling Technology, #12721), NRF1 (Cell Signaling Technology, #8052), YAP/TAZ (Cell Signaling, #8418) 4-HNE (Abcam, #ab46545) and Lamin A/C (Cell Signaling, #4777)
US$ 21.29
US$ 29.49
US$ 26.27
US$ 27.89
US$ 23.26
